GliaPharm SA

Swiss Biotech Association

Not a member

GliaPharm is a Swiss biotechnology company developing treatments for orphan neurological disorders. The company has developed a proprietary platform and pipeline of molecules targeting brain glial cells to restore brain metabolism deficits in orphan diseases linked to brain metabolism dysfunction.

http://www.gliapharm.com

Location

Chemin des Mines 9, 1202 Geneva, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2016
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

SIX

The Swiss Stock Exchange, representing more than a third of the European life sciences market capitalization and accounting for around 35% of the total market capitalization (as of 7 April 2021), the exchange is one of Europe’s leading listing venues for biotech companies.
Zürich

Not a member

Rowestil Consulting GmbH

Expertise in exploratory clinical drug/diagnostic development is available across a number of disease areas. Timing of input into the developmental strategy from regulatory and commercial perspectives is important in moving development programs towards success.
6318 Walchwil

Member

Zenith Technologies

Zenith Technologies - a Cognizant Company transforms Life Sciences manufacturing with a focus on delivering speed to value. We provide scalable IT & OT end-to-end smart factory solutions, from conception through completion, across the manufacturing lifecycle.
4500 Solothurn

Member